GTx
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, GTx sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
GTx: 15 sponsored US clinical trials, none currently recruiting.
GTx sponsors 15 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. 4 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.
Top-decile sponsor footprint
GTx ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
15 total, page 1 of 1
Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence
NCT03241342
GTx-024 as a Treatment for Stress Urinary Incontinence in Women
NCT02658448
Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer
NCT02463032
Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
NCT02368691
Phase II Study of GTx024 in Women With Metastatic Breast Cancer
NCT01616758
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
NCT01615120
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
NCT01420861
Phase II, Dose Finding Study of GTx-758
NCT01393119
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
NCT01355497
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
NCT01355484
Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
NCT01326312
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
NCT00467844
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
NCT00106691
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
NCT00129142
A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
NCT00028353
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 11 |
| Phase 3 | 4 |
Therapeutic Areas
How the GTx early-phase archive is shaped
15 indexed studies, none listed as recruiting (0% open); 10 completed (67%).
Phase mix: 4 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (2 trials), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
GTx: archived-pipeline peers nationwide
Peers matched on 15 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
GTx sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 archived trials
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this GTx page
15 registered trials is a research-attention snapshot, not an endorsement of GTx or any single study.
- None of GTx's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Prostate Cancer is the condition GTx studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
GTx pipeline card: 15 registered trials from official public datasets.Report a data error.